Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial
Titel:
Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial
Auteur:
Wierda, William G. Kipps, Thomas J. Dürig, Jan Griskevicius, Laimonas Stilgenbauer, Stephan Mayer, Jiri Smolej, Lukas Hess, Georg Griniute, Rasa Hernandez-Ilizaliturri, Francisco J. Padmanabhan, Swaminathan Gorczyca, Michele Gupta, Ira Nielsen, Tina G. Russell, Charlotte A.